Laboratorio Reig Jofre SA

FRA:FEQ1 (Spain)  
€ 3.09 (+0.32%) Jun 4
33.30
P/B:
1.13
Market Cap:
€ 245.07M ($ 266.60M)
Enterprise V:
€ 292.20M ($ 317.87M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Laboratorio Reig Jofre ( FRA:FEQ1 ) from 2007 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Laboratorio Reig Jofre stock (FRA:FEQ1) PE ratio as of Jun 05 2024 is 33.3. More Details

Laboratorio Reig Jofre SA (FRA:FEQ1) PE Ratio (TTM) Chart

To

Laboratorio Reig Jofre SA (FRA:FEQ1) PE Ratio (TTM) Historical Data

Total 1277
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Laboratorio Reig Jofre PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-05 35.1 2024-04-02 28.2
2024-06-04 35.1 2024-03-28 27.9
2024-06-03 35.0 2024-03-27 52.3
2024-05-31 32.2 2024-03-26 53.6
2024-05-30 31.8 2024-03-25 52.3
2024-05-29 31.4 2024-03-22 53.0
2024-05-28 30.7 2024-03-21 53.4
2024-05-27 30.7 2024-03-20 53.2
2024-05-24 30.8 2024-03-19 52.8
2024-05-23 30.9 2024-03-18 53.2
2024-05-22 30.6 2024-03-15 53.4
2024-05-21 30.6 2024-03-14 53.4
2024-05-20 30.2 2024-03-13 52.3
2024-05-17 30.4 2024-03-12 52.8
2024-05-16 30.7 2024-03-11 53.2
2024-05-15 30.7 2024-03-08 53.6
2024-05-14 31.1 2024-03-07 53.6
2024-05-13 32.2 2024-03-06 53.0
2024-05-10 31.0 2024-03-05 52.8
2024-05-09 28.4 2024-03-04 52.1
2024-05-08 28.3 2024-03-01 52.8
2024-05-07 28.4 2024-02-29 52.8
2024-05-06 27.7 2024-02-28 51.7
2024-05-03 27.9 2024-02-27 49.8
2024-05-02 27.8 2024-02-26 49.4
2024-04-30 27.7 2024-02-23 48.9
2024-04-29 27.6 2024-02-22 48.7
2024-04-26 28.2 2024-02-21 48.9
2024-04-25 28.4 2024-02-20 48.5
2024-04-24 28.3 2024-02-19 49.1
2024-04-23 28.4 2024-02-16 48.9
2024-04-22 28.1 2024-02-15 48.9
2024-04-19 28.5 2024-02-14 49.1
2024-04-18 29.3 2024-02-13 49.1
2024-04-17 29.6 2024-02-12 49.4
2024-04-16 28.9 2024-02-09 49.1
2024-04-15 29.1 2024-02-08 49.1
2024-04-12 30.2 2024-02-07 49.8
2024-04-11 30.1 2024-02-06 49.8
2024-04-10 30.2 2024-02-05 50.0
2024-04-09 28.6 2024-02-02 50.0
2024-04-08 28.4 2024-02-01 50.2
2024-04-05 28.5 2024-01-31 50.0
2024-04-04 27.9 2024-01-30 50.6
2024-04-03 28.2 2024-01-29 50.0

Laboratorio Reig Jofre SA (FRA:FEQ1) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.